ArticleClinical diabetes and endocrinology2024

Efficacy and safety of fixed dose combination of Sitagliptin, metformin, and pioglitazone in type 2 Diabetes (IMPACT study): a randomized controlled trial.

Mondal Aashish et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.